Small Molecule Outsourcing STREAM

  1. OPTIMA 7000 Fill Line 6/7/2021

    Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.

  2. Developing Long-Acting Contraceptive Injectables 7/1/2021

    Adare Pharma Solutions is crafting contraceptive injections that can last up to a year, increasing accessibility and allowing women to choose protection on their own terms.

  3. Little Patients, Big Challenges: Developing Pediatric Formulations 5/12/2025

    Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

  4. Cambrex Scientist Spotlight: Myoung Goo Kim 1/29/2025

    Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.

  5. Improve The Performance Of Your Small And Large Molecule Medicines 7/23/2024

    Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

  6. Considerations For Large-Scale API Production 3/1/2024

    Explore expert insights on selecting the right CDMO partner for large-scale API production as well as key considerations to ensure your small molecule API program is successful.

  7. Cambrex Scientist Spotlight: Kelly McGuill 1/29/2025

    McGuill is dedicated to inspiring the next generation of scientists. Her commitment to quality ensures that clients stay compliant and focused on advancing to the next phase of their projects.

  8. The Future Of Oral Solid Dose Development And Innovation 2/27/2025

    Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

  9. From Bench To Batch: Strategies For Scaling HPAPI Production

    Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

  10. Dramatic Reduction Of Solvent Usage In Pharmaceutical Spray Drying

    Using volatile processing aids to increase drug solubility in more environmentally friendly solvents, like methanol, reduces the amount of solvent required to manufacture amorphous solid dispersions (ASDs).